Resilience-h2020

Medical

Free · Designed for iPad

RESILIENCE Proyect A European Commission-funded project aimed at reducing the incidence of heart failure in cancer survivors Cancer survivors are at high risk for cardiovascular complications. Anthracyclines are an extremely effective treatment against many cancer types, but they can induce cardiac toxicity resulting in chronic heart failure. RESILIENCE Project tests a novel preventive intervention (remote ischemic conditioning) in patients at risk for anthracycline-induced cardiotoxicity. In addition, new diagnostic modalities will be used to identify anthracyclines-induced cardiotoxicity in its very early stages. RESILIENCE counts on a multidisciplinary consortium with the active participation of patients.

Ratings & Reviews

  • This app has not received enough ratings or reviews to display an overview.

Enjoy a smoother Resilience 2.0 experience! • New survey system • Cleaner, more intuitive interface • New support options for better assistance • Customize your app with language and theme options • General performance and design improvements

Version 2.0.1

The developer, Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.), indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy .

  • Data Not Collected

    The developer does not collect any data from this app.

    Privacy practices may vary based, for example, on the features you use or your age. Learn More

    Accessibility

    The developer has not yet indicated which accessibility features this app supports. Learn More

    Information

    • Provider
      • Centro Nacional de Investigaciones Cardiovasculares Carlos III F.S.P.
    • Size
      • 36.1 MB
    • Category
      • Medical
    • Compatibility
      Requires iOS 13.0 or later.
      • iPhone
        Requires iOS 13.0 or later.
      • iPad
        Requires iPadOS 13.0 or later.
      • iPod touch
        Requires iOS 13.0 or later.
      • Mac
        Requires macOS 11.0 or later and a Mac with Apple M1 chip or later.
      • Apple Vision
        Requires visionOS 1.0 or later.
    • Languages
      • English and Spanish
    • Age Rating
      13+
      • 13+
      • Learn More
      • Infrequent
        Medical Treatment Information

        Contains
        Messaging and Chat
        Health or Wellness Topics
    • Copyright
      • © 2020-2021 Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)
  • Developer Website
  • Privacy Policy

    • More by Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)

    You Might Also Like